Foster Dykema Cabot & Partners, LLC Amgen Inc Transaction History
Foster Dykema Cabot & Partners, LLC
- $1.28 Trillion
- Q4 2024
A detailed history of Foster Dykema Cabot & Partners, LLC transactions in Amgen Inc stock. As of the latest transaction made, Foster Dykema Cabot & Partners, LLC holds 420 shares of AMGN stock, worth $132,564. This represents 0.01% of its overall portfolio holdings.
Number of Shares
420
Previous 754
44.3%
Holding current value
$132,564
Previous $243 Million
54.94%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding AMGN
# of Institutions
3,167Shares Held
418MCall Options Held
8.25MPut Options Held
6.39M-
Vanguard Group Inc Valley Forge, PA52.7MShares$16.6 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29.4MShares$9.29 Billion0.31% of portfolio
-
Morgan Stanley New York, NY14.6MShares$4.6 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA13.2MShares$4.17 Billion0.65% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $169B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...